Trial ID or NCT#

NCT00991081

Status

NOT RECRUITING

Purpose

The major purpose of this exploratory developmental study will be to develop a patient-centered and feasible protocol for communicating genetic data as it relates to drug efficacy for smoking cessation inpatients receiving medication that is matched to individual genotypes associated with increased efficacy for bupropion or nicotine replacement therapy.

Official Title

Exploratory/Developmental Study of Pharmacogenetic Smoking Cessation Therapy.

Eligibility Criteria

Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No

Investigator(s)

Sean P. David, M.D., D.Phil.
Family medicine doctor
Associate Professor of Medicine (General Medical Disciplines) at the Stanford University Medical Center

Contact us to find out if this trial is right for you.

CONTACT

Sean David
(650) 498-4687